Renal Transplant Therapeutics Market Insights, Competitive Landscape, and Forecast Report 2024-2032 | Calcineurin Inhibitors Dominate Renal Transplant Therapeutics Market
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 08 2025
0mins
Source: Yahoo Finance
Market Growth Projection: The global renal transplant therapeutics market is expected to grow from USD 11.35 billion in 2024 to USD 18.39 billion by 2032, driven by an increase in kidney transplants and chronic kidney disease cases, with a CAGR of 6.29%.
Key Players and Innovations: Major companies like Novartis, Sanofi, and Astellas Pharma are leading the market, focusing on advancements in immunosuppressive therapies and new product approvals to enhance transplant success and patient outcomes.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
